StockGuru News: NextGen (NXGB) and Oxon Life Science Explore Opportunity for Scientific Collaboration
LONDON, UNITED KINGDOM–Apr 17, 2008 — NextGen Bioscience, Inc., a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has entered into discussion about collaboration with Oxon Life Science (”Oxon”), from whom it has recently acquired use, commercialisation and ownership rights of a patent application for the treatment of cancer, regarding the development of the latest stem cell technology that NXGB has acquired from Oxon in that transaction. NextGen CEO, Konstantinos Kardiasmenos, stated, “NextGen is excited about the possibility of close collaboration with Oxon. NextGen’s proprietary technology, which we have acquired from…